Cargando…

Tumor stroma Siglec15 expression is a poor prognosis predictor in colon adenocarcinoma

Sialic acid binding Ig-like lectin 15 (Siglec15) is considered a novel immune checkpoint and an emerging target for next-generation cancer immunotherapy. However, the significance of Siglec15 and its relationship with programmed death-ligand 1 (PD-L1) in colon adenocarcinoma (COAD) remain unknown. I...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhan, Weixiang, Bai, Fan, Cai, Yue, Zhang, Jianwei, Qin, Ge, Xie, Yuqian, Deng, Yanhong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2023
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10583595/ https://www.ncbi.nlm.nih.gov/pubmed/37859817 http://dx.doi.org/10.7150/jca.87618

Ejemplares similares

Siglec10—An immunosuppressor and negative predictor of survival prognosis in gliomas
por: Wang, Hesong, et al.
Publicado: (2022)

Tumour-stroma ratio and prognosis in gastric adenocarcinoma
por: Kemi, Niko, et al.
Publicado: (2018)

Analysis of a novel immune checkpoint, Siglec‐15, in pancreatic ductal adenocarcinoma
por: Chen, Xianlong, et al.
Publicado: (2022)

Development of an Immunohistochemical Assay for Siglec-15
por: Shafi, Saba, et al.
Publicado: (2022)

High ROR2 expression in tumor cells and stroma is correlated with poor prognosis in pancreatic ductal adenocarcinoma
por: Huang, Jianfei, et al.
Publicado: (2015)

Molecular profiling of stroma highlights stratifin as a novel biomarker of poor prognosis in pancreatic ductal adenocarcinoma
por: Robin, Fabien, et al.
Publicado: (2020)

A case of poorly differentiated adenocarcinoma with lymphoid stroma originated in the ascending colon diagnosed as lymphoepithelioma-like carcinoma
por: Kai, Kengo, et al.
Publicado: (2019)

Normalization cancer immunotherapy: blocking Siglec-15!
por: Cao, Guangchao, et al.
Publicado: (2019)

Siglec-15 promotes progression of clear renal cell carcinoma
por: Yang, Wen-Bo, et al.
Publicado: (2021)

Expression signature, prognosis value, and immune characteristics of Siglec-15 identified by pan-cancer analysis
por: Li, Baihui, et al.
Publicado: (2020)

Dynamic change in Siglec-15 expression in peritumoral macrophages confers an immunosuppressive microenvironment and poor outcome in glioma
por: Chen, Quan, et al.
Publicado: (2023)

Non-spatial and spatial heterogeneity revealed a suppressive immune feature of Siglec-15 in lung adenocarcinomas
por: Li, Baihui, et al.
Publicado: (2023)

ARL9 is upregulated and serves as a biomarker for a poor prognosis in colon adenocarcinoma
por: Yang, Hai-deng, et al.
Publicado: (2023)

Enhanced expression of GABRD predicts poor prognosis in patients with colon adenocarcinoma
por: Wu, Moxin, et al.
Publicado: (2020)

GPC1 Is Associated with Poor Prognosis and Treg Infiltration in Colon Adenocarcinoma
por: Liu, Ying, et al.
Publicado: (2022)

The PDGF Family Is Associated with Activated Tumor Stroma and Poor Prognosis in Ovarian Cancer
por: Li, Jiajia, et al.
Publicado: (2022)

Overexpression of carbohydrate sulfotransferase 15 in pancreatic cancer stroma is associated with worse prognosis
por: Matsuda, Yoko, et al.
Publicado: (2019)

GNG4, as a potential predictor of prognosis, is correlated with immune infiltrates in colon adenocarcinoma
por: Wang, Juan, et al.
Publicado: (2023)

Loss of KCNJ15 expression promotes malignant phenotypes and correlates with poor prognosis in renal carcinoma
por: Liu, Yang, et al.
Publicado: (2019)

Siglec Ligands
por: Gonzalez-Gil, Anabel, et al.
Publicado: (2021)

A novel defined cuproptosis-related gene signature for predicting the prognosis of colon adenocarcinoma
por: Luo, Bixian, et al.
Publicado: (2022)

Siglec-15 as an immune suppressor and potential target for normalization cancer immunotherapy
por: Wang, Jun, et al.
Publicado: (2019)

Siglec-15: a potential regulator of osteoporosis, cancer, and infectious diseases
por: Angata, Takashi
Publicado: (2020)

Neuraminidase and SIGLEC15 modulate the host defense against pulmonary aspergillosis
por: Dewi, Intan M.W., et al.
Publicado: (2021)

High affinity monoclonal antibody targeting Siglec-15 for cancer immunotherapy
por: He, Fei, et al.
Publicado: (2021)

Nanoparticles (NPs)-mediated Siglec15 silencing and macrophage repolarization for enhanced cancer immunotherapy
por: Liu, Xiaodi, et al.
Publicado: (2023)

Molecular cloning of porcine Siglec-3, Siglec-5 and Siglec-10, and identification of Siglec-10 as an alternative receptor for porcine reproductive and respiratory syndrome virus (PRRSV)
por: Xie, Jiexiong, et al.
Publicado: (2017)

Snail1 Protein in the Stroma as a New Putative Prognosis Marker for Colon Tumours
por: Francí, Clara, et al.
Publicado: (2009)

Siglec15 facilitates the progression of non-small cell lung cancer and is correlated with spinal metastasis
por: Liang, Haifeng, et al.
Publicado: (2022)

Higher heat shock factor 1 expression in tumor stroma predicts poor prognosis in esophageal squamous cell carcinoma patients
por: Liao, Yuehua, et al.
Publicado: (2015)

Coevolution of Siglec-11 and Siglec-16 via gene conversion in primates
por: Hayakawa, Toshiyuki, et al.
Publicado: (2017)

Immunopositivity for Siglec-15 in gastric cancer and its association with clinical and pathological parameters
por: Quirino, Michael Williams Leal, et al.
Publicado: (2021)

Identification of immune cell infiltration landscape for predicting prognosis of colorectal cancer
por: Wu, Xueqian, et al.
Publicado: (2023)

Preferential use of Siglec-1 or Siglec-10 by type 1 and type 2 PRRSV strains to infect PK15(S1–CD163) and PK15(S10–CD163) cells
por: Xie, Jiexiong, et al.
Publicado: (2018)

SIRT1 expression is associated with poor prognosis of lung adenocarcinoma
por: Li, Chong, et al.
Publicado: (2015)

Sialic acids in pancreatic cancer cells drive tumour-associated macrophage differentiation via the Siglec receptors Siglec-7 and Siglec-9
por: Rodriguez, Ernesto, et al.
Publicado: (2021)

Poor Prognosis of Gastric Adenocarcinoma with Decreased Expression of AHRR
por: Li, Yuan-fang, et al.
Publicado: (2012)

Soluble SIGLEC5: A New Prognosis Marker in Colorectal Cancer Patients
por: Montalbán-Hernández, Karla, et al.
Publicado: (2021)

Nuclear Ep-ICD Expression Is a Predictor of Poor Prognosis in “Low Risk” Prostate Adenocarcinomas
por: Assi, Jasmeet, et al.
Publicado: (2015)

SKA3 Up-regulation Promotes Lung Adenocarcinoma Growth and is a Predictor of Poor Prognosis
por: Sun, Rong-Li, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_la50vvbs06b8q5k9m93akue1qu